LXL Ventures
LXL Ventures is a closed-end alternative investment fund regulated by CMVM (ID: 2330) and managed by LXL Ventures, investing in venture capital with a minimum commitment of €250,000 and a 6 years lock-up period. It charges a 2% management fee, is open for subscriptions and reports accepting US persons.
| Min Investment | €250,000 |
|---|---|
| Redemptions | End of Term |
| Open to US | Yes (fund-reported) |
| Lock-up | 6 years |
| Fund Size (AUM) | €50M |
| Management Fee | 2% |
|---|---|
| Performance Fee | Not disclosed |
| Established | 2025 |
|---|---|
| CMVM ID | 2330 |
| Regulated By | CMVM |
Figures are reported by the fund manager.
Capital at risk. Past performance isn't indicative of future returns. Figures are shown in euro (EUR); fees reduce returns, and for investors funding from another currency amounts may rise or fall with exchange rates. This is not investment advice.
How these fees compare across all tracked funds: Golden Visa Fund Fee Index
About €70,000 in reported fund fees over 6 years on €500,000
Fees this fund has not reported are not included.
Not in the total because the fund has not reported them: redemption fee, performance fee.
Fees are fund-reported and simplified: actual fee bases, hurdles and timing vary by fund. This is an illustration, not a quote or a forecast. It leaves out legal, application, tax, FX and bank costs. Capital is at risk.
We'll email you the fees and terms listed for LXL Ventures, the 6-year cost table for your amount, plus the questions to ask the manager before you invest.
Investor decision panel
Golden Visa note: The manager states this fund is intended for Golden Visa applicants, but this claim is not shown as independently verified here.
LXL Ventures employs a hybrid portfolio strategy, 40% in U.S. companies, 35% in established Portuguese market names, and 25% in early-stage Portuguese technology companies. The tech sleeve is the key differentiator, embedding investors into Portugal's innovation ecosystem in a way that unlocks the country's new tax benefit scheme. The overall structure is designed to feel familiar to American investors while delivering European residency, EU mobility, and a pathway to Portuguese citizenship, all within a framework built for dual U.S. and Portuguese compliance.
We source from CMVM-regulated managers where applicable. Verify each fund's registration and GV suitability with counsel.
| CMVM Registration | 2330 |
|---|---|
| ISIN | PTTVN1IM0005 |
Provided by the fund manager. Review the fund's official documents before subscribing; Movingto has not independently verified their contents.
View all funds managed by this manager
| Minimum Investment | €250,000 |
|---|---|
| Fund Structure | Venture Capital |
| Lock-up Period | 6 years |
| Domicile | Portugal |
| Custodian | BNI Europa |
| Auditor | Not disclosed |
| ISIN | PTTVN1IM0005 |
| Typical Ticket | €500,000 |
| Risk Band | Not disclosed |
| Fund Status | Open |
| Inception Date | 2025 |
Figures are reported by the fund manager. Terms may vary by investor class.
We'll email you if the status or fees listed for LXL Ventures change, including if it closes to new investors.
| Frequency | End of Term |
|---|
Redemption terms may vary by investor class. Verify details with the fund manager.
View all funds in this category
Always confirm regulatory details with the fund manager and legal counsel before investing.
1 team member
Team members are employed by the fund manager, not Movingto. Profiles listed for directory comparison.
Have questions about LXL Ventures? Our specialists can help with eligibility, fees, timelines, and how it fits your Golden Visa plan — free and with no obligation.
Disclaimer: Your enquiry goes to Movingto. Movingto does not provide investment advice or introduce visitors directly to fund managers from this site. Capital is at risk. Target returns are fund-stated objectives, not forecasts or guarantees. Confirm all details against the fund prospectus/KID and qualified advisers.
You invest in units or shares of the fund, not directly in its underlying assets. Investment in funds involves risks, including the possible loss of principal. Where a fund is described as sustainable, ESG, or impact-oriented, those characteristics reflect the fund's own disclosures — check the fund's documents and any SFDR classification; a sustainability label does not by itself determine return or risk. Please read all fund documentation carefully before making any investment decisions. Past performance is not indicative of future results.
No published fund-stated objective
This fund hasn't specified a fund-stated objective, so no return is assumed. Enter your own assumption below to model an outcome — any figure you enter is your own, not the fund's.Ask Movingto what disclosure is missing, then confirm any objective against current fund documents.
Fee data incomplete
Missing Performance fee. Net-return estimates use known fees only and should not be read as final cost projections.
Project potential returns based on your investment parameters
Display returns after disclosed management and performance fees
Fund minimum: €250,000
Typical holding period
No published fund target — enter your own assumption
No published fund-stated objective: This fund hasn't specified a return objective, so no return is assumed. Any figure here is your own assumption, not the fund's or a Movingto projection. Actual performance may differ significantly, and capital is at risk. Confirm fund-specific information against current fund documents and qualified advisers.
Investment Risk Disclosure: The figures shown are an illustration, not a forecast. They are an estimate of future performance based on your own assumptions and on how this type of investment has behaved and/or on current market conditions, and are not an exact indicator — what you actually get will vary with market performance and how long you stay invested. This investment may result in a financial loss, as there is no capital guarantee. Past performance does not guarantee future results. Any future return is also subject to taxation, which depends on your personal situation and may change. Figures are shown in euro (EUR); if you fund from another currency, the amounts you pay and receive may rise or fall with exchange-rate movements. Confirm details against the fund's own documents and a qualified financial adviser before making any investment decision.
The IMGA Futurum Tech Fund is a specialised Venture Capital Fund (FCR) regulated by the CMVM and domiciled in Portugal. The fund targets high-growth technology companies in the "Atlantic Corridor" through a strategic partnership between IM Gestão de Ativos (IMGA), Portugal's largest independent asset manager, and Futurum Capital. It is marketed for the Golden Visa route via the Capital Transfer option, with eligibility subject to legal confirmation with zero real estate exposure, focusing on scalable startups bridging the Brazilian and Portuguese ecosystems.
IM Gestão de Ativos (IMGA)A CMVM-regulated Portuguese closed-end venture capital fund (FCR) managed by Indico Capital Partners and registered with CMVM under number 2356. Movingto has not yet independently verified the fund's Golden Visa eligibility basis or detailed terms.
The RYSE Golden Opportunities Fund invests exclusively in high growth digital health companies that are transforming how healthcare is delivered and financed. The strategy focuses on proven, revenue generating businesses that deliver measurable economic value to healthcare systems scalable, asset‑light models with strong competitive moats and clear paths to profitability. As the only Golden Visa fund dedicated to digital healthcare, it offers investors focused exposure to a sector undergoing structural, long‑term expansion, underpinned by rigorous research, disciplined risk management, and deep sector expertise.
The Fund lends to small and medium companies that operate in Portugal in the sectors defined in the LPA. The Fund shall invest in companies with good growth prospects and that are able to repay in full the loans provided. The Fund pursues the investment policy by investing, for limited periods of time in debt instruments, with the goal to earn an interest rate that is commensurable with the risk taken. The Fund will target conservative investments and that are protected by the equity amount hold by shareholders in target companies.
Finprop Capital, SGOIC, SAExplorer V is a CMVM-regulated private equity fund managed by Explorer Investments, focused on control investments in high-potential Portuguese companies. Backed by over 20 years of experience, the fund transforms lower mid-market businesses through active ownership, operational improvements, and international expansion.
Explorer InvestmentsINZ is a closed-ended Private Equity fund focused on renewable energy and energy-efficiency assets across Iberia, fully engineered for Golden Visa eligibility. Managed by STAG Fund Management and in line with UN Sustainable Development Goals, the fund aims to create steady, long-term value by investing in distributed solar, clean transportation, and low-carbon infrastructure using a careful, impact-focused approach.
STAG Fund ManagementIf this fund is full or doesn't meet your requirements, here are similar options with comparable risk profiles and investment strategies.
A CMVM-regulated, VC fund with access to European high-growth startups and corporates. Offers an option to qualify for IFICI tax regime (NHR 2.0).
The IMGA Futurum Tech Fund is a specialised Venture Capital Fund (FCR) regulated by the CMVM and domiciled in Portugal. The fund targets high-growth technology companies in the "Atlantic Corridor" through a strategic partnership between IM Gestão de Ativos (IMGA), Portugal's largest independent asset manager, and Futurum Capital. It is marketed for the Golden Visa route via the Capital Transfer option, with eligibility subject to legal confirmation with zero real estate exposure, focusing on scalable startups bridging the Brazilian and Portuguese ecosystems.
The RYSE Golden Opportunities Fund invests exclusively in high growth digital health companies that are transforming how healthcare is delivered and financed. The strategy focuses on proven, revenue generating businesses that deliver measurable economic value to healthcare systems scalable, asset‑light models with strong competitive moats and clear paths to profitability. As the only Golden Visa fund dedicated to digital healthcare, it offers investors focused exposure to a sector undergoing structural, long‑term expansion, underpinned by rigorous research, disciplined risk management, and deep sector expertise.
- At least 35% in the S&P 500 index, emphasizing stability and visibility. - Up to 5% in alternative assets (for example, venture debt) for diversification and downside protection.
- 35% in direct investment in leading Portuguese businesses, through the PSI-20 (Portugal's benchmark stock index) or venture debt into Portuguese private equity. - 25% in Portuguese tech startups with strong fundamentals, offering asymmetric upside while unlocking IFICI tax advantages.
In line with Golden Visa regulations, at least 60% is invested in Portuguese assets. The remaining 40% is allocated to American assets, prioritizing stable growth. The result is a diversified portfolio anchored in listed equities and established companies, with selective exposure to Portugal's high-growth tech sector, offering venture upside without the all-in risk of a traditional VC fund.
- Enables NHR 2.0: the fund's tech investment is structured so investors who move to Portugal can achieve IFICI status. It is the first Portuguese fund offering this as a built-in feature. - Invests in assets Americans prefer: through the Green Ocean partnership, the strategy prioritizes assets aligned with U.S. investors' priorities. - In-house cross-border legal and tax planning: backed by FRESH Legal Group, which represents approximately 10% of Americans living in Portugal, with lawyers licensed in Portugal, the U.S. and other jurisdictions. - Fully compliant in Portugal with U.S. structuring expertise: managed by Celtis Venture Partners, with over a decade of experience and a 100% Golden Visa approval rate. The fund provides PFIC reporting and QEF election support, and distribution policies take investor cash flow into account. - Cross-border financial advice: supported by Green Ocean, a Lisbon and San Francisco-based advisory firm focused on Americans moving to or investing in Portugal.
- Flat 20% tax on Portuguese-source employment and self-employment income for qualifying activities. - Exemption on most foreign-source income (dividends, interest, capital gains, royalties), excluding pensions and certain "black-listed" sources. - The regime is valid for 10 consecutive years, giving added optionality for investors who may move to Portugal during the investment period.
Portugal's Incentive for Scientific Research and Innovation (IFICI), often called NHR 2.0, is a tax regime introduced in the 2024 State Budget. It is designed to attract highly qualified professionals, researchers, and innovation-oriented individuals or entrepreneurs to Portugal.
The listed minimum investment is €250,000. Redemption frequency is End of Term and lock-up is 6 years. Confirm final terms in the fund documents.
Management fee: 2%. Performance fee: Not disclosed. Subscription fee: 2%. Missing fee fields should be treated as diligence gaps, not as zero-cost assumptions.
No fund-specific return objective is disclosed. Stated objectives are set by the fund and are not forecasts or guarantees. Past performance does not indicate future results and capital is at risk.
The profile lists CMVM ID 2330. The listed custodian is BNI Europa. Registration is a securities-regulation status, not a quality or Golden Visa signal — verify current registry status and documents before subscribing.
The profile marks this fund as Golden Visa intended by its manager. Fund-route evidence must still be confirmed against current law, fund documents, and the applicant's own legal file — eligibility is assessed per application, not guaranteed by the fund.
How does this Venture Capital fund stack up?
Compare fees, returns, and key terms across all Venture Capital Golden Visa funds.
See how this fund compares to other Venture Capital Golden Visa funds →Looking for all Golden Visa funds in one place?
Browse every fund with fees, returns, and key details side by side.
View the Complete Fund Directory →